GB Patent

GB2463452A — Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof

Assigned to Valeant Laboratories International Bermuda SRL · Expires 2010-03-17 · 16y expired

What this patent protects

Pharmaceutical compositions comprising a compound of the formula (1):or a pharmaceutically acceptable salt or tautomer thereof and a pharmaceutically acceptable carrier and compounds of formula (1) per se or pharmaceutically acceptable salts or tautomers thereof, excluding certai…

USPTO Abstract

Pharmaceutical compositions comprising a compound of the formula (1):or a pharmaceutically acceptable salt or tautomer thereof and a pharmaceutically acceptable carrier and compounds of formula (1) per se or pharmaceutically acceptable salts or tautomers thereof, excluding certain isomers. R1and R2are each hydrogen or methyl, provided at least one of R1and R2is hydrogen, and X is CHOH or C=O. The compounds are 1,3,4,6,7,11b-hexahydrobenzo(a)quinolizine compounds, more specifically desmethyl derivatives of tetrabenazine, and may be useful in treating various diseases, in particular movement disorders such as Huntington's disease or Tourette's syndrome, depression, inflammatory disease, asthma, multiple sclerosis or an autoimmune myelitis, psychoses, cognitive deficit, schizophrenia, anxiety, dementia or diabetes mellitus.

Drugs covered by this patent

Patent Metadata

Patent number
GB2463452A
Jurisdiction
GB
Classification
Expires
2010-03-17
Drug substance claim
No
Drug product claim
No
Assignee
Valeant Laboratories International Bermuda SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.